Source: http://radiotec.ru/article/13088
Timestamp: 2019-04-24 21:58:25+00:00

Document:
Ageev F.T. Rol' e'ndotelial'noj disfunkczii v razvitii i progressirovanii serdechno-sosu­disty'x zabolevanij // Serdechnaya nedostatochnost'. 2003. № 1. S. 22 – 25.
Almazov V.A., Berkovich O.A., Sitnikova M.Ju. i dr. E'ndotelial'naya disfunkcziya u bol'ny'x s debyutom ishemicheskoj bolezni v raznom vozraste // Kardiologiya. 2001. № 5. S. 26 – 29.
Almazov V.A., Gurevich V.S., Popov Ju.G. Struktura i funkcziya reczeptorov tromboczitov cheloveka // Gematologiya i transfuziologiya. 1990. № 10. S. 25 – 29.
Baluda M.V., Tlepushkov I.K. O diagnostike pretromboticheskogo sostoyaniya sistemy' gemostaza // Tromboz, gemostaz i reologiya. 2001. № 5. S. 79 – 82.
Vavilova T.V. Gemostaziologiya v klinicheskoj praktike. SPb.: Izdatel'stvo SPbGMU im. akad. I.P. Pavlova. 2005. 92 s.
Gomazkov O.A. Sistema e'ndotelinovy'x peptidov: mexanizmy' e'ndovaskulyarny'x patologij // Kardiologiya. 2000. № 1. S. 32 – 39.
Gomazkov O.A. E'ndotelin v kardiologii: molekulyarny'e, fiziologicheskie i patologicheskie aspekty' (obzor) // Kardiologiya. 2001. № 2. S. 50 – 58.
Gosudarstvenny'j doklad o sostoyanii zdorov'ya naseleniya Rossijskoj Federaczii v 2002 godu // Zdravooxranenie RF. 2004. № 1. S. 3 – 18.
Mordovin V.F., Ripp T.M., Sokolov S.E. i dr. Dinamika pokazatelej e'ndotelijzavisimoj vazodilataczii i gipotenzivnaya e'ffektivnost' e'nalaprila u paczientov s arterial'noj gipertenziej // Kardiologiya. 2001. № 6. S. 31 – 33.
Oganov R.G., Maslennikova G.Ja. Smertnost' ot serdechno-sosudisty'x i drugix xronicheskix neinfekczionny'x zabolevanij sredi trudosposobnogo naseleniya Rossii. Kardiovaskulyarnaya terapiya i profilaktika. 2002. № 3. S. 4 – 8.
Papayan L.P. Sovremennoe predstavlenie o mexanizme regulyaczii sverty'vaniya krovi // Tromboz, gemostaz i reologiya. 2003. №2. S. 7 – 11.
Pataraya S.A.. Preobrazhenskij D.V.. Sidorenko B.A., Masenko V.P. Bioximiya i fiziologiya semejstva e'ndotelinov // Kardiologiya. 2000. T. 40. № 6. S. 78 – 85.
Sergienko V.I., Bondareva I.B. Matematicheskaya statistika v klinicheskix issledovaniyax. M.: Ge'otarmed, 2001.
Shushlyapin O.I., Kononenko L.G., Manik I.M. Faktor Villebranda i ego rol' v disfunkczii e'ndoteliya pri ishemicheskoj bolezni serdcza: diagnostika, kriterii prognoza i perspektivny'e podxody' k terapii // Kardiologiya. 2001. № 2. S. 32 – 39.
Jushhuk E.N., Vasyuk Ju.A., Xadzegova A.B. i dr. E'ndotelial'naya disfunkcziya pri zabolevaniyax serdechno-sosudistoj sistemy' i metody' ee korrekczii // Klinicheskaya farmakologiya i terapiya. 2005. T. 14. № 3. S. 85 – 88.
Anderson T.J. Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction // Heart Failure Rev. 2003. V. 8. № 1. P. 71 – 86.
Anderson T.J., Meredith I.T., Charbonneau F., Yeung A.C., Frei V., Selwyn A.P., Ganz P. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans // Circulation. 1996. V. 93. № 9. P. 1647 – 1650.
Balligand J.L. New mechanisms of LDL-cholesterol induced endothelial dysfunction; correction by statins // Bull. Mem. Acad. R. Med. Belg. 2002. V. 157. № 10. P. 427 – 431.
Bassenge E. Endothelial regulation of coronary tone // Endothelial regulation of vascular tone. N.Y. etc.: Marcel Dekker, inc., 1992. P. 225 – 264.
Berliner J.A., Navab M., Fogelman A.M. et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics // Circulation. 1995. V. 91. P. 2488 – 2496.
Blann A.D. Von Willebrand factor and the endothelium in vascular disease // Brit. J. Biomed. Sci. 1993. V. 50. P. 124 – 134.
Blann A.D., Sheeran T.P., Emery P. Von Willebrand factor: increased level are leated to poor prognosis in systemic sclerosis and not to tissue autoantibodies // Brit. J. Biomed. Sci. 1997. V. 54. P. 670 – 673.
Bowie E.J.W. The role of von Willebrand factor in thrombosis // Thrombosis and its management. Edinburg: Churchill Livingstone. 1993. P. 134 – 140.
Davignon J., Ganz P. Role of endothelial dysfunction in atherosclerosis // Circulation. 2004. V. 1 09(23 Suppl 1). P. III27 – 32.
Harrison D.G. Cellular and molecular mechanisms of endothelial cell dysfunction // J. Clin. Invest. 1997. V. 19. P. 23 – 27.
Horio T. Heart failure and circulatory peptides // Nippon Naika Gakkai Zasshi. 2005. V. 94. P. 201 – 207.
Khan I.A. Role of endothelin-1 in acute myocardial infarction // Chest. 2005. V. 127. P. 1474 – 1476.
Negrusz-Kawechka M. The role of endothelins in human cardiovascular disease // Pol. Mercuriusz. Lek. 2001. V. 11. P. 444 – 446.
Teerlink J.R. Endothelins: pathophysiology and treatment implication in chronic heart failure // Current Heart Failure Reports. 2005. V. 2. P. 191 – 197.
Vanhoutte P.M. Endothelial control of vasomotor function: from health to coronary disease // Circ. J. 2003. V.67. P. 572 – 575.
Willey K.E., Davenport A.P. Nitric oxide-medulation of the endothelin-1 signaling pathway in the human cardiovascular system // Brit. J. Pharmacology. 2001. V. 132. P. 213 – 220.
Zolk O., Bohm M. The role of the cardiac endothelin system in heart failure // Nephrol. Dial. Transplant. 2000. V.15. P. 758 – 760.
Zolk O., Quattek J., Sitzler G. et al. Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure // Circulation. 1999. V. 99. P. 2118 – 2123.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.